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Indonesia with the total population of 
225,741,973, is one of the rapid developing 
countries that faces some serious challenges in 
health sector. The top 10 cause of deaths mixed 
between infection and non-infection causes. 
The high incidence of infection, the increasing 
number of non-communicable disease and the 
re-emerging illness makes it a triple burden, 
and all need to be managed concurrently and 
accordingly.1 While factors contributing to 
the health problems such as the demography 
changes, urbanization, mass travelling and also 
global warming  are not be easily to modified.2 
Human immunodeficiency virus (HIV) is 
one example of an emerging infection with 
total of 386 district of all province in Indonesia 
reported having such infection; with cumulative 
number of HIV infected patient from the year 
1987 to 2014 is 150,296 while AIDS is 55,799 
patients. The access to care only available for 
153,887 patients among all HIV/AIDS patients 
of whom 70% are eligible for anti-retroviral 
(ARV) treatment and of these only half adhered 
to ARV treatment.3 In addition to that, there is an 
increased risk of other emerging diseases such 
as Zika virus, Monkey pox or Hanta pulmonary 
syndrome since a sporadic cases were reported 
around the region.4
Beside new diseases, tuberculosis, dengue 
virus, malaria and diphteria are continuously 
reported in Indonesia and classified as re-
emerging illnesses.5 On this edition data on 
diphteria epidemiology in Indonesia will be 
shown by Karyanti et al.6 A recent outbreak of 
diphteria in Indonesia which involved almost 
all province in the country has led to a response 
named ORI (outbreak response of Immunization). 
Regardless of immunization, proper treatment 
including the distribution of anti-toxin and 
antibiotics are needed to stop the spread of 
this particular bacteria, further decreasing the 
mortality rate.6 In conclusion, the author of this 
paper mentioned that immunization gap needs 
to be handle systematically. Immunization 
data  released on 2017 showed that complete 
immunization was given only to 20% of 
targeted group, while almost 75% were either 
unvaccinated or unknown.7 During the outbreak 
of diphteria in Indonesia, the WHO also reported 
several countries with similar problem such as 
Bangladesh, Haiti and Yamen. It was shown 
that a coordination between doctors in clinic/
hospital with public health officer to conduct an 
epidemiological investigation, in conjunction 
with giving prophylaxis and assuring the logistics 
of anti-diphteria toxin and antibiotics were 
accessible were  the key of success in eliminating 
diphteria like it was in Bangladesh.
Adherence to treatment are multifactorial for 
all illnesses. First, is the duration of treatment and 
the potential adverse event due to the medication. 
The Ministry of Health of the Republic of 
Indonesia has support the early diagnosis 
of HIV and delivering treatment as soon as 
possible, in order to avoid transmission of the 
disease. Second, looking at another side of the 
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story for HIV infected patients, receiving ARV 
treatment as a long life treatment could possibly 
cause an adverse event somewhere along the 
line. Budiman et.al reported factors that might 
contribute to liver injury. His study shows that 
measuring baseline liver function test AST 
routinely might minimize the toxicity of ARV 
to patients particularly with a low body mass 
index. Last, despite the adherence to treatment 
and procedures in minimizing the risk of adverse 
event to medication, we are now facing the 
primary resistance virus that transmitted in the 
community as mentioned by Megasari et al.8 on 
her report regarding the transmission of drug 
resistance HIV virus to naïve patients in Bali.
The Indonesian government through the 
Indonesian Ministry of Health has established a 
collaboration and one health approaches to tackle 
the threat of diseases in the country, particularly 
in infectious diseases.9
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